Capital Impact Advisors, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Capital Impact Advisors, LLC
- $34.9 Million
- Q2 2024
A detailed history of Capital Impact Advisors, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital Impact Advisors, LLC holds 16,425 shares of AMPH stock, worth $760,806. This represents 1.88% of its overall portfolio holdings.
Number of Shares
16,425
Previous 16,425
-0.0%
Holding current value
$760,806
Previous $721,000
8.88%
% of portfolio
1.88%
Previous 0.96%
Shares
5 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.3MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$275 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$124 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$90.1 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$78.4 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$75.2 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.27B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...